<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17965" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Atrial Natriuretic Peptide</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sandefur</surname>
            <given-names>Cameron C.</given-names>
          </name>
          <aff>St. Bernards Medical Center in Jonesboro, AR</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jialal</surname>
            <given-names>Ishwarlal</given-names>
          </name>
          <aff>VA MEDICAL CENTER, MATHER , CA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cameron Sandefur declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ishwarlal Jialal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17965.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Atrial natriuretic peptide (ANP) is a hormone secreted from the right atrium in response to atrial stretch from hypervolemia as well as in response to hypertension. Since its discovery in the early 1980s, there have subsequent discoveries of other natriuretic peptides, including&#x000a0;brain or B-type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP). ANP and BNP are predominately produced by cardiomyocytes, while CNP is found more in the central nervous system and peripheral tissues.<xref ref-type="bibr" rid="article-17965.r1">[1]</xref>&#x000a0;ANP and BNP&#x000a0;have demonstrated properties leading to vasodilation, increase in natriuresis, diuresis, and antifibrotic and antihypertrophic effects within the heart.<xref ref-type="bibr" rid="article-17965.r1">[1]</xref></p>
      </sec>
      <sec id="article-17965.s2" sec-type="Etiology and Epidemiology">
        <title>Etiology and Epidemiology</title>
        <p>ANP was first discovered in 1981 by Adolfo J de Bold.<xref ref-type="bibr" rid="article-17965.r2">[2]</xref>&#x000a0;At that time, he found that within the myocytes of the atria, there were granules that were very similar morphologically and histochemically to other granules that were known to be hormone-producing cells.<xref ref-type="bibr" rid="article-17965.r2">[2]</xref>&#x000a0;This finding turned out to be a groundbreaking discovery. Over the ensuing decades, research has revealed that ANP has properties that lead to vasodilation, natriuresis, and reduction of the renin-angiotensin-aldosterone system (RAAS).<xref ref-type="bibr" rid="article-17965.r3">[3]</xref>&#x000a0;</p>
        <p>ANP acts to increase the glomerular filtration rate (GFR) within the kidney by dilating the afferent arterioles and constricting the efferent arterioles.<xref ref-type="bibr" rid="article-17965.r4">[4]</xref>&#x000a0;ANP also inhibits sodium and water reabsorption at varying levels of the nephron.<xref ref-type="bibr" rid="article-17965.r3">[3]</xref>&#x000a0;This combination results in a reduction of the secretion of Renin and, ultimately, the production of aldosterone. Neprilysin largely degrades ANP.</p>
        <p>There have also been more recent associations made between ANP and lipid metabolism&#x000a0;<xref ref-type="bibr" rid="article-17965.r5">[5]</xref>. Lafontan et al. report that ANP, as well as the other natriuretic peptides, B-type and C-Type, play a role in lipid mobilization in human white adipose tissue.<xref ref-type="bibr" rid="article-17965.r6">[6]</xref>&#x000a0;Engeli S et al. also report that the natriuretic peptides, including ANP, play a role in fat oxidation in human skeletal muscle.<xref ref-type="bibr" rid="article-17965.r7">[7]</xref>&#x000a0;In addition to this, research reveals the administration of ANP intravenously can lead to an increase in plasma levels of adiponectin.<xref ref-type="bibr" rid="article-17965.r8">[8]</xref><xref ref-type="bibr" rid="article-17965.r9">[9]</xref>&#x000a0;</p>
        <p>Adiponectin is an adipokine secreted by adipose tissue. Adiponectin has regulating effects on glucose and lipid metabolism resulting in increasing insulin sensitivity, reductions in both plasma glucose and free fatty acid (FFA) levels, as well as anti-inflammatory effects.<xref ref-type="bibr" rid="article-17965.r3">[3]</xref><xref ref-type="bibr" rid="article-17965.r10">[10]</xref><xref ref-type="bibr" rid="article-17965.r11">[11]</xref><xref ref-type="bibr" rid="article-17965.r12">[12]</xref><xref ref-type="bibr" rid="article-17965.r13">[13]</xref>&#x000a0;These associations still need further research, but&#x000a0;indeed represent a potentially significant finding that ANP could be much more than just a hormone to regulate vasodilation and natriuresis as was&#x000a0;initially thought.</p>
        <p>Additionally, there is evidence to suggest that there is a genetic component to the natriuretic peptides and their receptors. ANP and BNP are both encoded by natriuretic peptide precursors A and B (NPPA &#x00026; NPPB), respectively,&#x000a0;t found on chromosome 1.<xref ref-type="bibr" rid="article-17965.r14">[14]</xref>&#x000a0;ANP derives from its precursors pre-pro-ANP and pro-ANP. The NPPA gene has many variants. For example, there is a variant in the Japanese and Italian populations that leads to lower ANP levels, higher blood pressure, and subsequently more incidences of left ventricular hypertrophy.<xref ref-type="bibr" rid="article-17965.r15">[15]</xref>&#x000a0;</p>
        <p>Another variant that studied is rs5068. This particular variant demonstrated in a large sample study to result in higher ANP levels, lower blood pressures, reduced C-reactive protein levels, as well as increased amount of high-density lipoprotein (HDL) levels.<xref ref-type="bibr" rid="article-17965.r14">[14]</xref><xref ref-type="bibr" rid="article-17965.r16">[16]</xref><xref ref-type="bibr" rid="article-17965.r17">[17]</xref><xref ref-type="bibr" rid="article-17965.r18">[18]</xref><xref ref-type="bibr" rid="article-17965.r19">[19]</xref>&#x000a0;To further study this genetic component, researchers have conducted animal studies in mice where they knocked out either the gene for ANP or the gene for natriuretic peptide receptor-A (NPR-A). This modification resulted in the mice having an enlarged heart relative to those that were unaltered.<xref ref-type="bibr" rid="article-17965.r20">[20]</xref>&#x000a0;Again, this is an area requiring further research to illuminate the genetic component of ANP fully.</p>
      </sec>
      <sec id="article-17965.s3" sec-type="Testing Procedures">
        <title>Testing Procedures</title>
        <p>The measurement of BNP and NT-pro-BNP are both accepted assays for the diagnosis and management of heart failure. This test is via a standard blood draw.</p>
        <p>An assay for the mid-regional pro-ANP (MR-pro-ANP) is available and appears to have utility in the diagnosis and management of heart failure since it is more stable than ANP.<xref ref-type="bibr" rid="article-17965.r21">[21]</xref>&#x000a0;Future studies will reveal the value of this assay.</p>
      </sec>
      <sec id="article-17965.s4" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Again, ANP is not routinely measured. However, in the setting of BNP and NT-proBNP testing, comorbid conditions such as anemia, Type 2 diabetes, kidney disease, obesity, and acute coronary syndrome can affect the levels.<xref ref-type="bibr" rid="article-17965.r22">[22]</xref>&#x000a0;Levels are lower in obese patients and tend to be higher in the setting of kidney disease, acute coronary syndrome, and diabetes.<xref ref-type="bibr" rid="article-17965.r23">[23]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17965.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>ANP exerts its effects by increasing the amounts of cyclic guanosine monophosphate (cGMP) circulating in target tissues.<xref ref-type="bibr" rid="article-17965.r1">[1]</xref>&#x000a0;The impact on these target tissues ultimately&#x000a0;leads to vasodilation, diuresis, and inhibition of the renin-angiotensin-aldosterone system (RAAS) and sympathetic activity.<xref ref-type="bibr" rid="article-17965.r1">[1]</xref>&#x000a0;The discovery of ANP was followed by that of the brain or B-type natriuretic peptide (BNP) and C-type natriuretic peptide (CNP).</p>
        <p>BNP has since become clinically useful in the diagnosis of heart failure. Further, the PARADIGM trial in 2014 compared angiotensin receptor-neprilysin inhibitor (ARNi) with enalapril in patients with heart failure with a reduced ejection fraction.<xref ref-type="bibr" rid="article-17965.r24">[24]</xref>&#x000a0;Recall that neprilysin degrades ANP and BNP. The PARADIGM trial demonstrated that an ARNi, such as sacubitril-valsartan, reduced the rates of death and hospitalizations in this subset of patients when compared to enalapril.<xref ref-type="bibr" rid="article-17965.r24">[24]</xref>&#x000a0;There was also a significant decrease in measured BNP noted as well.<xref ref-type="bibr" rid="article-17965.r25">[25]</xref>&#x000a0;This decrease becomes clinically relevant as it pertains to ANP because two studies demonstrated a sustained increase in ANP among patients receiving an ARNi.<xref ref-type="bibr" rid="article-17965.r26">[26]</xref><xref ref-type="bibr" rid="article-17965.r27">[27]</xref>&#x000a0;This data helps to support the theory that ANP is beneficial in heart failure, most likely due to its ability to inhibit the RAAS.&#x000a0;&#x000a0;</p>
        <p>To further support this theory, we know that poorly controlled hypertension can lead to left ventricular hypertrophy and, ultimately, to heart failure. The heart failure can be with either a preserved or a reduced ejection fraction. Hypertension, itself, can result from sodium retention along with overactivation of RAAS and the sympathetic nervous system.<xref ref-type="bibr" rid="article-17965.r28">[28]</xref>&#x000a0;There have been studies to evaluate the effect of ANP on hypertension. In 1995, the research found that mice with a disrupted ANP gene, who ate a high sodium diet, developed hypertension.<xref ref-type="bibr" rid="article-17965.r29">[29]</xref>&#x000a0;This result was expounded upon further by Macherat et al. in 2012 when they demonstrated that patients with pre-hypertension had lower concentrations of ANP than&#x000a0;normotensive patients.<xref ref-type="bibr" rid="article-17965.r30">[30]</xref>&#x000a0;</p>
        <p>Studies have also determined that there is an inverse relationship between aldosterone and ANP so that patients with lower ANP levels actually have higher aldosterone levels, and therefore are more likely to be hypertensive.<xref ref-type="bibr" rid="article-17965.r31">[31]</xref><xref ref-type="bibr" rid="article-17965.r32">[32]</xref></p>
        <p>With these correlations in mind, it stands to reason that a therapy mimicking the actions of ANP would be beneficial in the treatment of hypertension. Unfortunately, ANP has a very short half-life of only 2&#x000a0;to 5 minutes.<xref ref-type="bibr" rid="article-17965.r3">[3]</xref>&#x000a0;This short of a half-life would require the patient to take the medication multiple times a day, which would be unreasonable in terms of patient compliance. However, there are ongoing studies with peptides that are similar in composition to ANP, but with a prolonged half-life; this could represent a&#x000a0;novel therapy for hypertension.&#x000a0;</p>
        <p>A few examples of these synthetic natriuretic peptides are anaritide and carperitide, which are forms of ANP. Carperitide actually received approval for use in Japan in 1995 for the treatment of patients with acute decompensated heart failure.<xref ref-type="bibr" rid="article-17965.r33">[33]</xref>&#x000a0;There is also a&#x000a0;recombinant&#x000a0;form of BNP called nesiritide. It obtained approval for use from the FDA in 2001 for patients with acute episodes of heart failure. However, the ASCEND-HF trial revealed that patients were prone to becoming hypotensive, and therefore Nesiritide is no longer recommended.<xref ref-type="bibr" rid="article-17965.r34">[34]</xref></p>
        <p>As it pertains to lipid metabolism, as described above, this is an area of ongoing research. The discoveries that the natriuretic peptides play a role in lipid mobilization within human white adipose tissue, skeletal muscle fat oxidation, and dissipation of energy in brown adipose tissue&#x000a0;all point to the fact that the natriuretic peptides are possibly associated with glucose homeostasis, fatty acid metabolism, and insulin sensitivity.<xref ref-type="bibr" rid="article-17965.r6">[6]</xref><xref ref-type="bibr" rid="article-17965.r7">[7]</xref><xref ref-type="bibr" rid="article-17965.r35">[35]</xref><xref ref-type="bibr" rid="article-17965.r7">[7]</xref><xref ref-type="bibr" rid="article-17965.r6">[6]</xref><xref ref-type="bibr" rid="article-17965.r36">[36]</xref>&#x000a0;It has been hypothesized that there may even be an associated predictive value in the development of diabetes.<xref ref-type="bibr" rid="article-17965.r37">[37]</xref>&#x000a0;Given that obesity is currently a huge health problem, this could also represent a future area for therapeutic intervention if a peptide in similar composition to ANP but with a longer half-life is formulated.</p>
      </sec>
      <sec id="article-17965.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As discussed above, there continue to be many new discoveries with regards to atrial natriuretic peptide. We have discovered its effects on the vasculature, on the kidney, and lipolysis, among others. Each of these has a wide range of impacts on various pathologies, from hypertension to heart failure to even metabolic syndrome. In addition to continued studies into ANP, an interdisciplinary approach is also necessary to help tackle these disorders. From nurses checking vitals and drawing labs to pharmacists helping to dose future therapeutic regimens to physicians understanding the physiology behind ANP, it will require a team effort.&#x000a0;</p>
      </sec>
      <sec id="article-17965.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17965&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17965">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17965/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17965">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17965.s8">
        <title>References</title>
        <ref id="article-17965.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishikimi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kuwahara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Atrial and brain natriuretic peptides: Hormones secreted from the heart.</article-title>
            <source>Peptides</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>111</volume>
            <fpage>18</fpage>
            <page-range>18-25</page-range>
            <pub-id pub-id-type="pmid">29859763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Bold</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Borenstein</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Veress</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Sonnenberg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.</article-title>
            <source>Life Sci</source>
            <year>1981</year>
            <month>Jan</month>
            <day>05</day>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-94</page-range>
            <pub-id pub-id-type="pmid">7219045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cabassi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Volpi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
              <collab>Jr</collab>
            </person-group>
            <article-title>Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Jul</month>
            <day>02</day>
            <volume>20</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">31269783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Volpe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carnovali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mastromarino</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.</article-title>
            <source>Clin Sci (Lond)</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>57</fpage>
            <page-range>57-77</page-range>
            <pub-id pub-id-type="pmid">26637405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hamet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tremblay</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.</article-title>
            <source>Mol Cell Biochem</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>334</volume>
            <issue>1-2</issue>
            <fpage>53</fpage>
            <page-range>53-65</page-range>
            <pub-id pub-id-type="pmid">19937369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lafontan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Berlan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crampes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sengenes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galitzky</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Control of lipolysis by natriuretic peptides and cyclic GMP.</article-title>
            <source>Trends Endocrinol Metab</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>130</fpage>
            <page-range>130-7</page-range>
            <pub-id pub-id-type="pmid">18337116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engeli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Birkenfeld</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Badin</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Bourlier</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Louche</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Viguerie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thalamas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Montastier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Larrouy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harant</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>de Glisezinski</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lieske</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reinke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beckmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Langin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.</article-title>
            <source>J Clin Invest</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>122</volume>
            <issue>12</issue>
            <fpage>4675</fpage>
            <page-range>4675-9</page-range>
            <pub-id pub-id-type="pmid">23114600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukamoto</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ogai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Asai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagamachi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shintani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Minamino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Asakura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kishimoto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Funahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tomoike</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kitakaze</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Jun</month>
            <day>02</day>
            <volume>53</volume>
            <issue>22</issue>
            <fpage>2070</fpage>
            <page-range>2070-7</page-range>
            <pub-id pub-id-type="pmid">19477358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birkenfeld</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Boschmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engeli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arafat</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Luft</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Atrial natriuretic peptide and adiponectin interactions in man.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>8</issue>
            <fpage>e43238</fpage>
            <pub-id pub-id-type="pmid">22916229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shimomura</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kishida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagaretani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Furuyama</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Komuro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ouchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kihara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tochino</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okutomi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Horie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aoyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Funahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsuzawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.</article-title>
            <source>Nat Med</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>731</fpage>
            <page-range>731-7</page-range>
            <pub-id pub-id-type="pmid">12068289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shibata</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ouchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kihara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shiojima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pimentel</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kumada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schiekofer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Funahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Colucci</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Adiponectin-mediated modulation of hypertrophic signals in the heart.</article-title>
            <source>Nat Med</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>1384</fpage>
            <page-range>1384-9</page-range>
            <pub-id pub-id-type="pmid">15558058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shibata</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pimentel</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Takemura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kihara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Funahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ouchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.</article-title>
            <source>Nat Med</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>1096</fpage>
            <page-range>1096-103</page-range>
            <pub-id pub-id-type="pmid">16155579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costello-Boerrigter</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A new role for the natriuretic peptides: metabolic regulators of the adipocyte.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Jun</month>
            <day>02</day>
            <volume>53</volume>
            <issue>22</issue>
            <fpage>2078</fpage>
            <page-range>2078-9</page-range>
            <pub-id pub-id-type="pmid">19477359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ping</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.</article-title>
            <source>J Biol Eng</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">29344085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubattu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bigatti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lanzani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stanzione</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zagato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Manunta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marchitti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Venturelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stella</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2006</year>
            <month>Aug</month>
            <day>01</day>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>499</fpage>
            <page-range>499-505</page-range>
            <pub-id pub-id-type="pmid">16875975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Juji&#x00107;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leosdottir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x000d6;stling</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gudmundsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Melander</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Magnusson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malm&#x000f6; preventive project study.</article-title>
            <source>BMC Med Genet</source>
            <year>2013</year>
            <month>Jun</month>
            <day>24</day>
            <volume>14</volume>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">23799939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Boerrigter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cataliotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Costello-Boerrigter</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>McKie</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Heublein</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Lahr</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Averna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rodeheffer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Aug</month>
            <day>02</day>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>629</fpage>
            <page-range>629-36</page-range>
            <pub-id pub-id-type="pmid">21798427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cefalu'</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Noto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Cavera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pagano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sapienza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Averna</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.</article-title>
            <source>Diabetes Care</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>2850</fpage>
            <page-range>2850-6</page-range>
            <pub-id pub-id-type="pmid">23637347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Davis-Dusenbery</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Ghorbani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spagnolli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tainsh</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Del Monte</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vandenwijngaert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Swinnen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Buys</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Newton-Cheh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Atrial natriuretic peptide is negatively regulated by microRNA-425.</article-title>
            <source>J Clin Invest</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>123</volume>
            <issue>8</issue>
            <fpage>3378</fpage>
            <page-range>3378-82</page-range>
            <pub-id pub-id-type="pmid">23867623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Peshock</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Shohet</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging accurately estimates LV mass in a transgenic mouse model of cardiac hypertrophy.</article-title>
            <source>Am J Physiol</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>274</volume>
            <issue>2</issue>
            <fpage>H679</fpage>
            <page-range>H679-83</page-range>
            <pub-id pub-id-type="pmid">9486274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nadar</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in Routine Heart Failure Clinical Care.</article-title>
            <source>Card Fail Rev</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-56</page-range>
            <pub-id pub-id-type="pmid">30847246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayo</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Colletti</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Brain natriuretic peptide (BNP) testing in the emergency department.</article-title>
            <source>J Emerg Med</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-10</page-range>
            <pub-id pub-id-type="pmid">17044584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r23">
          <label>23</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Novack</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zubair</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Natriuretic Peptide B Type Test</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>23</day>
            <pub-id pub-id-type="pmid">32310596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lefkowitz</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Rizkala</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Rouleau</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Swedberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zile</surname>
                <given-names>MR</given-names>
              </name>
              <collab>PARADIGM-HF Investigators and Committees</collab>
            </person-group>
            <article-title>Angiotensin-neprilysin inhibition versus enalapril in heart failure.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Sep</month>
            <day>11</day>
            <volume>371</volume>
            <issue>11</issue>
            <fpage>993</fpage>
            <page-range>993-1004</page-range>
            <pub-id pub-id-type="pmid">25176015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Velazquez</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Morrow</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>DeVore</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Duffy</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Ambrosy</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>McCague</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Braunwald</surname>
                <given-names>E</given-names>
              </name>
              <collab>PIONEER-HF Investigators</collab>
            </person-group>
            <article-title>Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.</article-title>
            <source>N Engl J Med</source>
            <year>2019</year>
            <month>Feb</month>
            <day>07</day>
            <volume>380</volume>
            <issue>6</issue>
            <fpage>539</fpage>
            <page-range>539-548</page-range>
            <pub-id pub-id-type="pmid">30415601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nougu&#x000e9;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pezel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sadoune</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arrigo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beauvais</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Launay</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cohen-Solal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vodovar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Logeart</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2019</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>598</fpage>
            <page-range>598-605</page-range>
            <pub-id pub-id-type="pmid">30520545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gaggin</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Szymonifka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Apple</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Effect of Neprilysin Inhibition on Various&#x000a0;Natriuretic Peptide Assays.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Mar</month>
            <day>26</day>
            <volume>73</volume>
            <issue>11</issue>
            <fpage>1273</fpage>
            <page-range>1273-1284</page-range>
            <pub-id pub-id-type="pmid">30898202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodfriend</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Calhoun</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy.</article-title>
            <source>Hypertension</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>518</fpage>
            <page-range>518-24</page-range>
            <pub-id pub-id-type="pmid">14732721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>John</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Krege</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hagaman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hodgin</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Smithies</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.</article-title>
            <source>Science</source>
            <year>1995</year>
            <month>Feb</month>
            <day>03</day>
            <volume>267</volume>
            <issue>5198</issue>
            <fpage>679</fpage>
            <page-range>679-81</page-range>
            <pub-id pub-id-type="pmid">7839143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macheret</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heublein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Costello-Boerrigter</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Boerrigter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McKie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bellavia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mangiafico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Sandberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Malatino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rodeheffer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cataliotti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Oct</month>
            <day>16</day>
            <volume>60</volume>
            <issue>16</issue>
            <fpage>1558</fpage>
            <page-range>1558-65</page-range>
            <pub-id pub-id-type="pmid">23058313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buglioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cannone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cataliotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sangaralingham</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Heublein</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Rodeheffer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Dess&#x000ec;-Fulgheri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sarzani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.</article-title>
            <source>Hypertension</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-53</page-range>
            <pub-id pub-id-type="pmid">25368032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Buglioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sangaralingham</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Rodeheffer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Sarzani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burnett</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>93</volume>
            <issue>8</issue>
            <fpage>980</fpage>
            <page-range>980-990</page-range>
            <pub-id pub-id-type="pmid">30077215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Roles of atrial natriuretic peptide and its therapeutic use.</article-title>
            <source>J Cardiol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-70</page-range>
            <pub-id pub-id-type="pmid">20884176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Connor</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Starling</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Dickstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hasselblad</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Heizer</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Komajda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Massie</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Nieminen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Reist</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rouleau</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Swedberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Anker</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Atar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Battler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Botero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bohidar</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clausell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Corbal&#x000e1;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Costanzo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dahlstrom</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Deckelbaum</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dunlap</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ezekowitz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Felker</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Gennevois</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hollander</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Howlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Hudson</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Kociol</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Krum</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Laucevicius</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ndez</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Ponikowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tanomsup</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teerlink</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Triposkiadis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Troughton</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Whellan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zannad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Califf</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Effect of nesiritide in patients with acute decompensated heart failure.</article-title>
            <source>N Engl J Med</source>
            <year>2011</year>
            <month>Jul</month>
            <day>07</day>
            <volume>365</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-43</page-range>
            <pub-id pub-id-type="pmid">21732835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bordicchia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amri</surname>
                <given-names>EZ</given-names>
              </name>
              <name>
                <surname>Ailhaud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dess&#x000ec;-Fulgheri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sarzani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.</article-title>
            <source>J Clin Invest</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>122</volume>
            <issue>3</issue>
            <fpage>1022</fpage>
            <page-range>1022-36</page-range>
            <pub-id pub-id-type="pmid">22307324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verboven</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jocken</surname>
                <given-names>JWE</given-names>
              </name>
              <name>
                <surname>Blaak</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.</article-title>
            <source>Obes Rev</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>1243</fpage>
            <page-range>1243-1259</page-range>
            <pub-id pub-id-type="pmid">28901677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17965.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magnusson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jujic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hedblad</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Engstr&#x000f6;m</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Persson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Struck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morgenthaler</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Newton-Cheh</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Melander</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>638</fpage>
            <page-range>638-45</page-range>
            <pub-id pub-id-type="pmid">22112816</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
